| Identification | Back Directory | [Name]
Teslexivir | [CAS]
1075798-37-6 | [Synonyms]
BTA074
AP 611074
Teslexivir
Benzeneacetic acid, 2-bromo-4-carboxy-5-methoxy-, 1-[2-[2-methyl-6-(1-piperidinyl)phenyl]-2-[4-(phenylmethyl)phenyl]hydrazide] | [Molecular Formula]
C35H36BrN3O4 | [MDL Number]
MFCD31692355 | [MOL File]
1075798-37-6.mol | [Molecular Weight]
642.58 |
| Hazard Information | Back Directory | [Uses]
Teslexivir (BTA074) is a potent antiviral agent. Teslexivir is a potent and selective inhibitor of the interaction between two essential viral proteins, E1 and E2, an association that is a necessary step in the DNA replication and thus viral production for Human Papilloma Virus (HPV) 6 and 11. Teslexivir can be used for condyloma research[1]. | [References]
[1] Atta-ur-Rahman. Frontiers in Clinical Drug Research - Anti Infectives: Volume 8. 2021, 8, 55-100. |
|
|